TGFB1 and neoplasm: Under certain conditions, typically following exposure to IL-10 or TGF-β, dendritic cells within the tumor microenvironment and cancer cells can initiate the development of Tregs limiting effector responses by inhibition of cytotoxic T-cells thus impairing anti tumor immunity [16,17].